BioStable Science & Engineering out of Austin, Texas won FDA clearance for its HAART 200 aortic annuloplasty device indicated for repair of congenital bicuspid aortic valve in patients with aortic valve insufficiency. A similar device, the HAART 300 for people with all three aortic valve leaflets, was cleared by the FDA earlier this year.
The H (Read more...)